Compare SOC & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SOC | PRGO |
|---|---|---|
| Founded | 2020 | 1887 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 2.0B |
| IPO Year | 2021 | 2013 |
| Metric | SOC | PRGO |
|---|---|---|
| Price | $5.14 | $13.67 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 3 |
| Target Price | $17.33 | ★ $19.33 |
| AVG Volume (30 Days) | ★ 8.5M | 2.4M |
| Earning Date | 05-14-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 10.28% |
| EPS Growth | ★ 54.61 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $800,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $73.55 | $1.02 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.88 | $9.23 |
| 52 Week High | $24.96 | $22.65 |
| Indicator | SOC | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 52.74 | 51.41 |
| Support Level | $4.10 | $13.58 |
| Resistance Level | $5.38 | $13.89 |
| Average True Range (ATR) | 0.30 | 0.58 |
| MACD | 0.07 | -0.15 |
| Stochastic Oscillator | 51.50 | 10.17 |
Sable Offshore Corp is a Houston-based independent upstream company focused on developing the Santa Ynez Unit in federal waters offshore California. The company operates as one reportable oil and gas segment and is engaged in the acquisition, development, exploration, and production of oil and natural gas.
Perrigo is a pure-play consumer healthcare product manufacturer and distributor. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. It plays in a number of over-the-counter categories including pain, skincare, women's health, and nutrition. Perrigo also competes in Europe, Australia, and parts of Asia, where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.